These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2457068)

  • 21. The synergistic neutralization of Newcastle disease virus by two monoclonal antibodies to its haemagglutinin-neuraminidase protein.
    Russell PH
    Arch Virol; 1986; 90(1-2):135-44. PubMed ID: 3729723
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newcastle disease virus: the effect of monoclonal antibody in the overlay on virus penetration and the immunoselection of variants.
    Russell PH
    J Gen Virol; 1984 Apr; 65 ( Pt 4)():795-8. PubMed ID: 6546769
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of a variable epitope on the Newcastle disease virus hemagglutinin-neuraminidase protein.
    Hu S; Wang T; Liu Y; Meng C; Wang X; Wu Y; Liu X
    Vet Microbiol; 2010 Jan; 140(1-2):92-7. PubMed ID: 19729254
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Nucleotide sequence of the haemagglutinin-neuraminidase (HN) gene of a Malaysian heat resistant viscerotropic-velogenic Newcastle disease virus (NDV) strain AF2240.
    Tan WS; Lau CH; Ng BK; Ibrahim AL; Yusoff K
    DNA Seq; 1995; 6(1):47-50. PubMed ID: 8746461
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Monoclonal antibodies identify a strain-specific epitope on the HN glycoprotein of Newcastle disease virus strain Australia-Victoria.
    Iorio RM; Lawton KA; Nicholson PM; Bratt MA
    Virus Res; 1984 Oct; 1(7):513-25. PubMed ID: 6085438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological relationships between mumps virus and parainfluenza viruses studied with monoclonal antibodies.
    Orvell C; Rydbeck R; Löve A
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1929-39. PubMed ID: 3018131
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nucleotide sequence of the fusion and haemagglutinin-neuraminidase glycoprotein genes of Newcastle disease virus, strain Ulster: molecular basis for variations in pathogenicity between strains.
    Millar NS; Chambers P; Emmerson PT
    J Gen Virol; 1988 Mar; 69 ( Pt 3)():613-20. PubMed ID: 3351479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleotide sequence of the hemagglutinin-neuraminidase gene of Newcastle disease virus avirulent strain D26: evidence for a longer coding region with a carboxyl terminal extension as compared to virulent strains.
    Sato H; Hattori S; Ishida N; Imamura Y; Kawakita M
    Virus Res; 1987 Sep; 8(3):217-32. PubMed ID: 3687202
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of amino acid residues important to the neuraminidase activity of the HN glycoprotein of Newcastle disease virus.
    Iorio RM; Syddall RJ; Glickman RL; Riel AM; Sheehan JP; Bratt MA
    Virology; 1989 Nov; 173(1):196-204. PubMed ID: 2479168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of neutralizing monoclonal antibodies to regions of the fusion protein of respiratory syncytial virus expressed in Escherichia coli.
    Lounsbach GR; Bourgeois C; West WH; Robinson JW; Carter MJ; Toms GL
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2559-65. PubMed ID: 7506297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A single amino acid substitution in the hemagglutinin-neuraminidase of Newcastle disease virus results in a protein deficient in both functions.
    Sheehan JP; Iorio RM
    Virology; 1992 Aug; 189(2):778-81. PubMed ID: 1641990
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of pathotype-specific structural features and cleavage activation of Newcastle disease virus membrane glycoproteins using antipeptide antibodies.
    Hodder AN; Selleck PW; White JR; Gorman JJ
    J Gen Virol; 1993 Jun; 74 ( Pt 6)():1081-91. PubMed ID: 8509761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus.
    Iorio RM; Glickman RL; Sheehan JP
    J Gen Virol; 1992 May; 73 ( Pt 5)():1167-76. PubMed ID: 1375279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus expressed by a recombinant baculovirus.
    Niikura M; Matsuura Y; Hattori M; Onuma M; Mikami T
    Virus Res; 1991 Jun; 20(1):31-43. PubMed ID: 1927050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Expression of a cloned hemagglutinin-neuraminidase gene from Newcastle disease virus in murine myeloma cells].
    Risinskaia NV; Fegeding KV; Vasilenko OV; Sudarikov AB
    Mol Biol (Mosk); 2001; 35(5):920-7. PubMed ID: 11605546
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Avian adeno-associated virus-based expression of Newcastle disease virus hemagglutinin-neuraminidase protein for poultry vaccination.
    Perozo F; Villegas P; Estevez C; Alvarado IR; Purvis LB; Saume E
    Avian Dis; 2008 Jun; 52(2):253-9. PubMed ID: 18646454
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A single amino acid substitution in the haemagglutinin-neuraminidase protein of Newcastle disease virus results in increased fusion promotion and decreased neuraminidase activities without changes in virus pathotype.
    Estevez C; King DJ; Luo M; Yu Q
    J Gen Virol; 2011 Mar; 92(Pt 3):544-51. PubMed ID: 21123551
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunogenic properties of recombinant ectodomain of Newcastle disease virus hemagglutinin-neuraminidase protein expressed in Escherichia coli.
    Wong SK; Tan WS; Omar AR; Tan CS; Yusoff K
    Acta Virol; 2009; 53(1):35-41. PubMed ID: 19301949
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pathogenicity of antigenic variants of Newcastle disease virus Italian strain selected with monoclonal antibodies.
    Meulemans G; Gonze M; Carlier MC; Petit P; Burny A; Long LE
    Ann Rech Vet; 1987; 18(4):371-4. PubMed ID: 2454065
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutralization escape mutants of type A influenza virus are readily selected by antisera from mice immunized with whole virus: a possible mechanism for antigenic drift.
    Lambkin R; McLain L; Jones SE; Aldridge SL; Dimmock NJ
    J Gen Virol; 1994 Dec; 75 ( Pt 12)():3493-502. PubMed ID: 7527838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.